ArticleFrontiers in immunology2026
Early functional maturation of anti-Spike antibodies predicts efficient SARS-CoV-2 RNA clearance.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Viral RNA clearance following mild SARS-CoV-2 infection varies considerably among individuals, but the early humoral immune features underlying this heterogeneity remain incompletely understood. Methods: We investigated whether the kinetics and functional maturation of the antibody response were associated with viral RNA clearance in a longitudinal study of 78 healthcare professionals infected with the ancestral Wuhan SARS-CoV-2 strain and followed for up to three years. Participants were stratified according to viral RNA clearance kinetics as nonpersistent (≤21 days) or persistent (>21 days). Humoral responses were longitudinally characterized by seroconversion kinetics, antibody isotypes and IgG subclasses, affinity, cross-variant recognition, and neutralizing activity. Results: Nonpersistent individuals exhibited accelerated seroconversion to Spike and receptor-binding domain antigens within the first 11 days after symptom onset, accompanied by significantly greater neutralizing activity against the ancestral strain. In contrast, persistent individuals displayed delayed seroconversion, prolonged IgM responses, and reduced coordination among IgG subclasses during acute infection, consistent with delayed early humoral maturation. Total immunoglobulin levels did not distinguish the groups, whereas cross-variant antibody recognition during acute infection remained limited and predominantly strain-focused in both groups. During convalescence, durable anti-Spike IgG responses were maintained independently of persistence status, without significant differences in cross-variant breadth. Vaccination robustly enhanced antibody titers, variant recognition, and ACE2-blocking responses in both groups. Discussion: Accelerated functional maturation of the early anti-Spike antibody response, rather than overall antibody magnitude, was associated with efficient SARS-CoV-2 RNA clearance. These findings identify early functional maturation of the humoral response as an immunological correlate of efficient viral clearance and provide mechanistic insight into the immune processes underlying heterogeneous SARS-CoV-2 RNA clearance during mild infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.